3,125,000 Shares Repro Med Systems, Inc. Common Stock PURCHASE AGREEMENTPurchase Agreement • June 22nd, 2020 • Repro Med Systems Inc • Surgical & medical instruments & apparatus • New York
Repro Med Systems, Inc., a New York corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Piper Sandler & Co. and Canaccord Genuity LLC are acting as representatives (in such capacity, the “Representatives”), an aggregate of 3,125,000 shares (the “Firm Shares”) of Common Stock, $0.01 par value per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to an aggregate of 468,750 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement (this “Agreement”) are herein collectively called the “Securities.”
